Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18085540 | 0.86 | — | — | |
| SCHEMBL260698 | 0.86 | — | — | |
| SCHEMBL18085532 | 0.86 | — | — | |
| SCHEMBL3371973 | 0.79 | TSHR (0.52) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| SCHEMBL16047312 | 0.77 | TSHR (0.44) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| SCHEMBL31646679 | 0.76 | TSHR (0.56) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| SCHEMBL12629261 | 0.74 | TSHR (0.54) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| SCHEMBL25526271 | 0.74 | — | — | |
| SCHEMBL21603029 | 0.73 | ALDH1A1 (0.72) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| SCHEMBL1768045 | 0.72 | TSHR (0.50) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11695158-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | MU IONIC SOLUTIONS CORPORATION (JP) | 2023-07-04 | — | — | US | disclosed |
| US-20210320334-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | MU IONIC SOLUTIONS CORPORATION (JP) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11695158-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | SLC9A2, VDAC1, SCO2 | TSHR 2418/4885ALDH1A1 1748/4885MAPK1 1826/4885 |
| US-20210320334-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | SLC9A2, VDAC1, SCO2 | TSHR 2418/4885ALDH1A1 1748/4885MAPK1 1826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.